Bonnefont-Rousselot D, Segaud C, Jore D, Delattre J, Gardès-Albert M
Laboratoire de Biochimie, Hôpital de la Salpêtrière, Paris, France.
Radiat Res. 1999 Mar;151(3):343-53.
This study was designed to evaluate the antioxidant effect of probucol on peroxidation of low-density lipoproteins (LDLs) initiated by oxygenated free radicals (O2*-) and ethanol-derived peroxyl radicals (RO2*) generated by gamma radiolysis. Initial radiolytic yields related to the markers of lipid peroxidation [i.e. decrease in endogenous alpha-tocopherol, formation of thiobarbituric acid-reactive substances (TBARS) and conjugated dienes] were determined as a function of LDL concentration (1.5 and 3 g l(-1), expressed as total LDL) and in the absence or the presence of probucol at different concentrations (2.3 x 10(-6), 3.5 x 10(-6), 9 x 10(-6) and 20.5 x 10(-6) mol l(-1)). Our results showed that probucol was able to decrease not only the yields of TBARS and conjugated dienes but also the levels of these peroxidation products obtained at high doses (2500 Gy) compared to LDLs without probucol. Under our conditions, probucol displayed an optimal antioxidant effect for an initial concentration in LDLs equivalent to 15 probucol molecules per LDL particle, which corresponded to a pharmacologically relevant concentration of probucol. Moreover, our data showed that probucol was unable to react with RO2* and thus did not protect LDL vitamin E from free radical attack. In addition, the scavenging capacity of probucol on O2*- appeared to be very poor, and probucol more likely reacted with LDL intermediate radical products. Finally, a very significant steady-state level of probucol remained in LDLs at high doses (up to 2500 Gy), equivalent to at least 40% of the initial concentration of probucol. This addressed the question of a mechanism for regeneration of probucol in LDLs. Our results as a whole suggested that the antioxidant effect of probucol in vivo could not be explained by its scavenging capacity with regard to RO2*/O2*- free radicals.
本研究旨在评估普罗布考对由γ辐射分解产生的氧化自由基(O2*-)和乙醇衍生的过氧自由基(RO2*)引发的低密度脂蛋白(LDL)过氧化的抗氧化作用。确定了与脂质过氧化标志物相关的初始辐射分解产率[即内源性α-生育酚的减少、硫代巴比妥酸反应性物质(TBARS)和共轭二烯的形成],作为LDL浓度(1.5和3 g l(-1),以总LDL表示)以及在不同浓度(2.3 x 10(-6)、3.5 x 10(-6)、9 x 10(-6)和20.5 x 10(-6) mol l(-1))的普罗布考存在或不存在时的函数。我们的结果表明,与不含普罗布考的LDL相比,普罗布考不仅能够降低TBARS和共轭二烯的产率,还能降低在高剂量(2500 Gy)下获得的这些过氧化产物的水平。在我们的条件下,当LDL中的初始浓度相当于每个LDL颗粒15个普罗布考分子时,普罗布考表现出最佳的抗氧化作用,这对应于普罗布考的药理学相关浓度。此外,我们的数据表明,普罗布考不能与RO2反应,因此不能保护LDL维生素E免受自由基攻击。另外,普罗布考对O2-的清除能力似乎非常差,并且普罗布考更可能与LDL中间自由基产物反应。最后,在高剂量(高达2500 Gy)下,LDL中仍存在非常显著的普罗布考稳态水平,相当于普罗布考初始浓度的至少40%。这解决了LDL中普罗布考再生机制的问题。我们的整体结果表明,普罗布考在体内的抗氧化作用不能用其对RO2*/O2*-自由基的清除能力来解释。